FIRST IN CLASS FIXED COMBINATION QUINOLONE-NSAID FOR BACTERIAL CONJUNCTIVITIS (OPHTHALMOLOGY, OCULAR INFECTIONS, INFLAMMATION)

FIRST IN CLASS FIXED COMBINATION QUINOLONE-NSAID FOR BACTERIAL CONJUNCTIVITIS (OPHTHALMOLOGY, OCULAR INFECTIONS, INFLAMMATION)
Product Description

Game changer FDC with Levofloxacin, a fluoroquinolone with a broad spectrum of action and activity on bacteria (Gram+ and Gram-) most frequently implicated in ocular infections, and ketorolac, NSAID with powerful anti-inflammatory effect and analgesic effect. Phase II studies completed.

Please, contact us to receive more information and to discuss partnership on a global scale.

Presentation: eyedrop, 5ml.IP Protected

NTC S.r.l.

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

NTC S.r.l.

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from NTC S.r.l. (28)

NTC S.r.l. resources (7)